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Abstract 
Purpose  
A systematical literature review evaluating the effect of dietary counselling in treating weight loss 
and improving energy intake in patients with advanced cancer with different stages of cachexia. 
Principal results 
Five publications were retrieved, of which three were randomized. Two out of five studies 
showed less weight loss with dietary counselling (+1% weight gain vs. -1.5% weight loss, 
p=0.03, 1.4 kg vs. -2 kg, p<0.05), two presented positive effect on energy intake (92% of total 
caloric need vs. 73%, p<0.01, 1865±317 kcal vs. 1556±497 kcal, ns).  
Conclusion 
Dietary counseling can effect energy intake and body weight, however, apperent heterogeneity 
between studies is present. Based on these results there is not enough proof of evidence that dietary 
counselling given to patients with cancer is beneficial for improving weight or energy balance in the 
different cachexia stages. Nutrition is an essential part of cachexia treatment as it is not considered 
possible to increase or stabilize weight if nutritional needs are not met.  
 
 
Keywords: Cancer; Cachexia; Dietary counselling; Weight loss; Nutritional status; Energy 
intake 
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1. Introduction 
Weight loss is common in patients with progressive cancer and has major impact on 
both morbidity and mortality. The aetiology of cancer related weight loss is not fully 
understood, even though cancer cachexia usually is considered the main contributor [1, 2]. 
Cachexia is by definition associated with underlying illness and characterised by loss of lean 
tissue with or without loss of fat mass [2]. The definition also states that weight loss in 
advanced cancer is a consequence of a combination of metabolic abnormalities and reduced 
food intake leading to negative energy balance [2]. Reduced food intake may be a result of a 
wide variety of symptoms directly or indirectly limiting oral intake e.g. loss of appetite, taste 
change, dysphagia and pain [3]. The impact of impaired food intake on weight loss in 
cachexia has not yet been elucidated and remains undefined, and the clinical benefits of 
dietary intervention in the treatment of cachexia are not clarified.  
The development of cachexia in cancer should be seen as a continuum moving through 
three different phases, namely pre-cachexia, cachexia and refractory cachexia [2]. During this 
cachexia trajectory, nutritional and dietary practices that promote energy balance may be of 
varying importance [2, 4], however, the scientific foundation to supports these assumptions 
are ambiguous. In pre-cachectic patients, the focus is on prevention of weight loss and the 
response to dietary treatment is expected to be fair [5, 6]. In patients with cachexia, dietary 
treatment is most likely insufficient to reverse cachexia since other factors such as metabolic 
and inflammatory changes are involved [2, 5]. If the patient has entered a stage of refractory 
cachexia, the response to dietary treatment is no longer anticipated due to very advanced or 
rapidly progressive cancer unresponsive to anti-cancer therapy [2]. Even if nutritional or 
dietary treatment do not influence weight loss or survival it may be highly significant when it 
comes to eating- and weight loss-related distress, relief of certain symptoms,  quality of life 
and social meaningfulness for the patients [6, 7].  
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There are basically only three techniques/methods that are used to increase energy 
intake in patients; parenteral nutrition (PN), enteral nutrition (EN) or dietary counselling with 
advices aiming to increase oral intake. In dietary counselling the focus is commonly to 
increase intake of energy dense foods, increase meal frequency and/or to use oral liquid 
nutritional supplements (ONS) [8, 9]. Former reviews and guidelines have concluded that the 
benefits from PN or EN in advanced cancer are limited [10, 11]. The overall aim of this 
systematic review was therefore to evaluate the evidence of the effect of dietary counselling 
in treating weight loss and improving energy intake in patients with advanced cancer and 
different stages of cachexia. Secondary research questions were if dietary counselling is 
effective in improving physical function or quality of life.  
 
2. Methods 
2.1. Search strategy and selection criteria 
Studies with adult patients with advanced cancer that evaluated the effect of oral dietary 
interventions were included. Studies were excluded if the main aim was to evaluate the effect 
of either PN or EN or if the intervention was selected nutritional compounds such as certain 
vitamins, fatty acids, proteins or amino acids.  Studies were also excluded if they at baseline 
did not report data necessary to classify cachexia or if only treatment with curative intent was 
given. The recent consensus criteria for diagnosis of cancer cachexia were used to classify 
cachexia [2]. Patients with weight loss 5% at inclusion were classified as pre-cachectic. 
Patients with weight loss >5% or body mass index (BMI) <20 and weight loss >2% or weight 
loss >2% and sarcopenia were classified as cachectic. Simple starvation should be ruled out as 
a reason for weight loss. Patients were considered having refractory cachexia if the criterions 
for cachexia were fulfilled and expected survival was ≤ 3 months, WHO performance status 
was ≥3 or they did not respond to anti-cancer therapy. The classification into cachexia stages 
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was based on the information provided in the articles; no attempts were made to obtain further 
information from the study authors. 
Primary outcomes of interest in this review were weight (measured in kg, pound or percent 
change in lean body mass, total body mass or fat mass) and energy intake (measured as kcal, 
kJ or MJ, absolute intake and/or energy balance). Secondary outcomes were physical 
functioning and quality of life (QoL).   
This review considered quantitative study designs including randomised controlled trials 
(RCT’s), quasi-RCT, cohort studies, pre-post study design and case control studies.  
Case series with 10 or less participants were not included, neither were qualitative studies. 
Only studies published in full-text in peer-reviewed journals were included. Language was 
limited to English, German and Scandinavian languages.   
The literature search was conducted in PubMed (includes MEDLINE), Embase (through 
OvidSP), and The Cochrane Central Register of Controlled Trials (CENTRAL), last search 
date April 2013. Searches were performed together with a trained research advisor in 
literature searches. The search strategy for all databases is reported in supplementary material. 
Appropriate strategies were developed for each database. A hand search of the references list 
of the selected papers was also performed.  
 
2.2. Study selection and data extraction 
All records identified by the database searches were collated into a computer based reference 
management system (EndNote x5) and checked for duplicates. After deduplication titles and 
abstracts were reviewed and assessed for inclusion independently by two authors (AB and 
TRB). Disagreements were resolved by discussion with third author (TSS) and reasons for 
excluding trials were reported. If abstracts were missing the full text papers were screened. 
The Prisma statement for reporting systematic reviews was used [12]. 
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2.3. Description of study quality and content 
The content of each included study was analysed following reading full text articles using 
methodological indications from the Cochrane Handbook for Systematic Reviews of 
Interventions [13], and summarized according to a standardized form. The authors of the 
Cochrane handbook state that there is no single recommended instrument for assessing the 
quality of trials when the systematic review also includes non-randomized trials. Therefore, a 
pragmatic quality assessment model based on the Cochrane guidelines was applied for the 
non-randomized trials were used.  
 
3. Results 
3.1. Search results and selection of studies  
The literature review retrieved 634 papers (Fig. 1). Three studies were added after a hand 
search of the reference lists of full-text articles assessed for eligibility. After excluding 
duplicate studies, and studies that did not meet the inclusion criteria based on reading title and 
abstract, 23 papers were selected for full-text examination. Eighteen papers were excluded; 
nine in which the target population was not clearly defined as patients with advanced cancer 
and/or treatment with curative intent was given [9, 14-19], four in which there was not given 
enough information to classify cachexia [20-23] and five in which the effect of other 
interventions than dietary counselling were evaluated [24-28]. The present review is thus 
based on two non-randomized studies and three RCT’s. Three studies included only cachectic 
patient [29-31] (Table 1), one study reported inclusion of  both pre-cachectic and cachectic 
patients [32] and one reported inclusion of patients with all stages of cachexia [33] (Table 2). 
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3.2. Dietary counselling in studies including patients with cachexia  
Three studies had included patients that could be classified as cachectic, two RCT’s [29, 30] 
and one non-randomized study [31]. The available data could not exclude starvation as the 
reason for weight loss. The studies represents in total  419 patients with a variety of type and 
stage of cancer. The studies are summarized in the next paragraph. 
Baldwin (2011) [29]. 358 patients with gastrointestinal (GI) cancers (n=277) and non-small 
cell lung cancer (NSCLC) (n=81), were randomized to four groups, 1) dietary counselling 
aiming to increased energy intake by 600 kcal using regular food, 2) oral liquid nutritional 
supplements (ONS) (240 ml providing 588 kcal/day), 3) a combination of dietary advice, 
ONS and vitamins or 4) ad lib intake. The intervention period lasted for six weeks during 
chemotherapy. After this the patients were allowed to continue with their intervention if 
desired. They were followed for one year. The overall compliance with prescribed ONS was 
low. In the first week, 31% of the patients reported taking all of their prescribed drink. This 
decreased to 19% at week six. Analyses of data on dietary intake were not performed due to 
low compliance with food diaries (25%- 17%). Mean weight change after six weeks of 
intervention was small (0.0 kg to – 0.7 kg), and no statistically significant differences between 
the four groups were found. After one year 68 (19%) patients were alive, of whom 31 had 
received dietary counselling (group 1 and 3). These patients reported a weight gain of 4.8 kg 
compared to 1.4 kg (p<0.05) among patients not receiving counselling. However, the most 
important predictor of weight gain was survival and not nutritional intervention. The authors 
suggest that weight gain might be a surrogate marker of tumor response to chemotherapy. 
Physical performance and QoL was evaluated, but no differences between the groups were 
found. 
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Breitkreuz (2005) [30]. Twenty-three patients with advanced colorectal or gastric cancer 
receiving chemotherapy were randomised to 1) fat-enriched ONS (237 ml providing 355 kcal) 
in combination with usual care (nutritional advice before treatment and thereafter every 2nd 
weeks) or 2) control group, usual care only. Energy intake was higher in the intervention 
group than the control group (1865 kcal vs. 1556 kcal, not statistically significant). After 56 
days the intervention patients had gained in average 1.4 kg while the control group lost 2 kg 
(p<0.05). Fat free mass increased 1 kg in the intervention group and decreased 1 kg in the 
control group (p<0.05). The intervention group had stable albumin values during the study 
while a fall (-4.57+1.86 g/l, p<0.05) was seen in the control group.  In the intervention group 
ratings of quality of life leisure activity increased (4.9+0.9 vs 6.7+0.7 out of 10 units, p<0.01) 
compared to a detoriation in control group (exact figures were not available, p<0.01). 
van den Berg (2010) [31]. Thirty-eight head and neck (HN) cancer patients (stages II-IV) 
receiving radiotherapy were included and assigned to treatment based on postal code. The 
intervention group received systematic dietary counselling (1-2 times a week) during 
radiotherapy and follow up (20 weeks) aiming to meet total caloric need and protein 
requirements. High energetic ONS (type not stated) and EN was used when energy intake was 
too low.  The control group received standard care (dietary counselling twice before start of 
RT and advice by a nurse during treatment, patients losing >10% of weight received EN). 
Two weeks after RT both groups had lost 3% of their initial weight. Two months after 
treatment the intervention group increased weight (1%) while the control group continued to 
lose weight (-1.5%), p=0.03.  
 10 
 
3.3. Dietary counselling in studies including patients with pre-cachexia, cachexia, and 
refractory cachexia  
Evans (1987) [32] reported inclusion of both pre-cachectic and cachectic patients and 
evaluated the effect of dietary counselling. The RCT included 180 patients with metastatic 
NSCLC (n=102) and Duke’s D colorectal carcinoma (CRC) (n=90), all receiving 12 weeks 
chemotherapy.  At randomization patients were stratified by weight loss (5% or >5%) and 
then randomized to one of three groups, 1) standard nutrition (dietary counselling to meet 
total caloric need), 2) augmented nutrition (protein, zinc and magnesium supplementation in 
addition to dietary counselling) or 3) control (ad libitum intake). Fifty one patients received 
standard nutrition and of these 22 (43%) were cachectic. Sixty patients received the 
augmented nutrition (28 (47%) cachectic) and 69 were allocated to the control group (33 
(48%) cachectic). Patients receiving nutritional intervention (group 1 and 2) had higher 
caloric intake compared to patients in the control group, covering respectively 91-92% and 
62-73% of total caloric need (p<0.01). In spite of this, the overall weight change between 
treatment groups during chemotherapy did not differ. The patients with NSCLC lost weight, 
median -1.2% in the two intervention groups and -3.1% in the control group (ns). The patients 
with CRC gained weight, 0.8 % in the intervention groups and 2.1% in the control group (ns). 
For both tumor types a positive association between caloric intake and weight change was 
found. The association was strongest among patients with NSCLC. No analyses were 
performed to differentiate the effect between patients being cachectic or pre-cachectic. The 
intervention had no effect on survival, response to chemotherapy or treatment toxicity. 
Percival (2013) [33]. Two hundred and forty-three patients with thoracic cancer (NSCLC 
(77%), small cell lung cancer (SCLC) (13%), mesothelioma (4%), no histology available 
(6%)) underwent nutritional assessment (height, weight, weight loss, body composition, 
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nutritional intake, and nutritional impact symptoms) before cancer treatment. Eighty-four 
(35%) were identified as malnourished and reported weight loss or BMI consistent with 
cachexia or refractory cachexia. Information from the nutritional assessment together with 
patient’s likely prognosis was used to develop an individualized intervention plan (high 
protein and energy foods, dietary fortification, ONS). There was no control group. After one 
month 61 (73%) of the malnourished patients could be re-evaluated. Fourteen (23%) had 
received dietary counselling and 47 (77%) had received dietary counselling in combination 
with ONS. Twenty two (37%) patients had gained weight (median 2.0 kg), 20 (33%) had 
stable weight and 19 (32%) lost weight (median –3.0 kg). The type of nutritional intervention 
was not essential for weight development, but it seemed that patients who gained weight were 
younger (mean age 68 vs 71 years, p=0.04) than patients that stabilized or lost weight.  
 
3.4. Summary of findings 
Most studies included patients with a variety of cancer diagnosis, even if NSCLC and HN 
were most common. Three out of five studies included only patients with cachexia, one both 
pre-cachectic and cachectic patients and one with all stages. On the basis of available data it 
was not possible to exclude that weight loss was due to starvation. The effect of dietary 
counselling on energy intake (absolute intake and/or energy balance) was evaluated in two 
RCTs. The results indicated that it was possible to increase energy intake by various 
combinations of high energy foods, fortifications and ONS. All five studies evaluated the 
effect of dietary counselling on weight. Two studies reported statistical significant differences 
in weight loss among patients receiving dietary counselling compared to patients not 
receiving counselling. The secondary outcome QoL was evaluated in one study but no effect 
was found.  Physical functioning was evaluated in two studies where one found increased 
leisure activities and psychological functions in favour of dietary counselling. No analyses 
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were performed to differentiate effects between pre-cachectic and cachectic patients in any of 
the studies. 
 
3.5. Quality of evidence 
The quality of the included studies is summarized in Table 3. Two studies were carried out on 
a small number of patients (N<40) [30, 31], three studies were RCTs and two of these studies 
performed sample size estimations [29, 32]. Four out of five studies had a comparative control 
group. Two studies [29, 32] described control patients to receive respectively “ad libitum 
diet” and “no nutritional support” while one study [31] described that patients in the control 
group getting “standard care” received dietary advice by a dietitian twice before starting 
radiotherapy continuing with weekly body weight measurements by a nurse.. One of five 
studies reported allocation concealment, intention-to-treat analysis and presented data on 
compliance to dietary counselling [29]. Studies could not be directly compared with each 
other due to different intervention periods, outcomes, registrations and follow-up. All 
included studies described body weight as one of their outcomes, but only two [29, 32] 
showed data on energy intake and only one study had data on physical function and QoL 
parameters [29].  
 
4. Discussion 
This systematic literature review identified five studies evaluating the effectiveness of 
dietary counselling in treating weight loss and improving energy intake in patients with 
advanced cancer and cachexia. Counselling included increased intake of energy dense foods, 
increased meal frequency and/or use of oral liquid nutritional supplements (ONS). Most 
studies showed some effect on body weight,  stabilization or increase, during the intervention 
either in subgroups or at some given time point.  There is not enough evidence to conclude 
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whether patients with advanced cancer and different cachexia stages benefit from dietary 
counselling.   
Only two included studies [30, 32] used energy intake and energy balance as outcome 
variables. Both studies showed that it was possible to improve energy intake with dietary 
counselling but one of of the studies did not reach statistical significance. Nevertheless, the 
effect of increased intake was not followed by increased body weight. These findings are 
consistent with the findings of a recent Cochrane review and meta-analysis that did not find a 
consistent effect of oral nutritional interventions on energy intake and weight gain in 
malnourished cancer patients [34]. The explanation for such findings may be that weight loss 
in cancer patients in general, and particularly in advanced cancer, is not always a result of low 
energy intake and malnutrition but rather occurs as a result various combination of low intake, 
increased tumor activity and metabolic changes [35, 36]. This assumption is in accordance 
with the international cachexia definition [2], declaring that cachexia cannot be treated with 
nutrition alone. Today this is perceived as an indication for the use of multimodal treatment in 
cancer cachexia [37], suggesting that cancer cachexia needs to be treated with a combination 
of physical exercise to counteract inactivity atrophy and catabolism, pharmacological agents 
affecting metabolism, and nutritional intervention to secure sufficient energy intake [6]. 
Nevertheless, for clinical practice and the design of future studies it is important to determine 
if response to nutritional interventions can be expected in cachexia and thus clearify the role 
of nutritional interventions. 
Most studies in this review have grouped together patients with different diagnosis 
receiving different treatments. This leads to a heterogeneity that may have interfered with the 
results of the interventions. It is obvious that  patients experiencing starvation and mainly  
lose weight due to readily reversible factors such as untreated candida stomatitis, will have 
more effect from dietary counselling than patients with any stage of cachexia [2, 4, 5]. For  
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classification of cachexia it is important to rule out simple starvation as the reason for weight 
loss [2]. The main difference between starvation and cachexia is that refeeding reverses 
starvation but is less effective for cachexia. However, the studies included in this review did 
not provide data making such an  exclusion possible e.g information about nutritional impact 
symptoms lacked in all of them and thus the possibility to assess if this was contributing to 
patient weight loss. It is very challenging to exclude starvation and untangle the relative 
contribution of symptoms, low food intake and metabolic changes to weight loss in cancer 
patients, as this varies both between patients and in the individual patient with time [3]. 
Normally is assessment of nutritional status used to decide if a patient is starved or not. 
However, the assessment instruments normally used overlap the cachexia classification and is 
therefor not suitable for excluding starvation  [38]. A separation between starvation and 
cachexia could be achieved if information about nutritional impact symptoms causing reduced 
food intake were available, such as mechanical intestinal obstructions,constipation, stomatitis 
and untreated pain. 
In dietary intervention trials both non-compliance as well as an risk of  adoption of the 
intervention program in the control group (cross over) may be a problem and tend to equalise 
outcomes between the groups, minimising the chance of seeing an effect even if there is one. 
Unfortunately it is not possible to administer an intervention trial based on counselling as a 
double-blind experiment in order to conclude that any difference that develops between the 
groups is directly caused by the factor under investigation [39].  It is therefore of great 
importance to evaluate the compliance when evaluating the effect of dietary counselling. 
However, most studies in this review lack such an evaluation. In the study of Baldwin et al. 
[29] the compliance to ONS was evaluated. They found that only 31% of the patients reported 
taking all of their prescribed drink. This may have had an devastating effect on the result, as it 
is demonstrated that maximum weight gain is dependent on full compliance [24]. ONS are 
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often used in dietary intervention trials since they usually are nutritional complete and easy to 
use, nevertheless, compliance can be challenging. Lack of compliance may be related to taste 
and smell problems aggravated by chemotherapy side effects. In addition, most supplements 
are sweet-flavored which may not appeal to all patients. 
To further complicate the estimation of effectiveness of dietary interventions in this 
review, both the length of interventions and the interventions themselves varied considerably 
and not all studies were randomized. Other intervention studies in cachexia have 
demonstrated that positive single arm interventions studies often are followed by RCTs where 
there are no difference between active arm and placebo [40]. Even if most of the included 
studies were randomized it is still a challenge to conclude if a true control group existed since 
the patients received “usual care”. “Usual care” was also some kind of nutritional 
intervention, although less intensive and poorly described, and the consequence may be 
reduced effect size.  
In intervention trials it is of course essential that the primary outcome is of relevance. 
When the intervention is dietary increased energy intake and stabilized body weight might be  
objective measurements of the intended effect. However, one challenge in using weight as an 
outcome is that it does not take into account that changes in weight may be caused by other 
factors (edema, ascites and increased tumor load) and not only changes in muscle and fat 
mass. More objective measures such as CT scans may thus be more reliable when muscle and 
fat mass is of interest [41]. Another discussion is whether improved or stabilized body weight 
is transferable to other, more patient centered outcomes such as quality of life parameters and 
physical function. This was the reason for choosing these as the secondary outcomes in this 
review. The evidence from the retrieved studies was however very limited as one of the 
retrieved studies used this outcome. It could also be discussed if more traditional oncological 
outcomes such as survival, tumor response or toxicity should have been used as outcomes in 
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this review, since there is an abundance of evidence that malnourished patients have reduced 
survival [42]. Only one of the reviewed studies evaluated survival, treatment response and 
toxicity [32] but did not find any improvements with nutritional intervention. However, for 
future studies it may be relevant to have a more oncologic focus on outcomes especially since 
it is not proven that reversal of nutritional deficits improves survival [43].  
Several studies were excluded from this review due to missing or insufficient 
information on cancer staging, treatment intent and weight loss before inclusion and/or BMI 
because it was impossible to classify the patients according to the international consensus 
classification system for cachexia [2]. Studies were also excluded if patients receiving 
curative treatment were included. Because of this two of the most promising studies regarding 
dietary counselling from the analysis unfortunately had to be excluded [20, 21]. These two 
studies demonstrate that early individualized dietary counselling is effective in preventing 
weight loss in cancer but the results cannot be transferred directly to patients with advanced 
cancer and cachexia. However, it is worth to mention the most striking finding from these two 
studies, that individualized dietary counselling based on regular foods was the most effective 
intervention to prevent weight loss in cancer patients, far more effective than e.g. ONS [20, 
21].  
This is the first review attempting to resolve a question clinicians often struggle with 
in their daily practice. Which patients should receive what kind of dietary counselling? It is of 
great significance that this difficult question is untangled. It is important both when deciding 
how to treat patients, and when considering how and what information to give to patients and 
their loved ones. Several get caught in the general nihilism surrounding this issue, while 
others become too proactive resulting in frustration for cancer patients and families feeling 
that counting of calories wrongfully occupies the last time of their life. Future studies 
investigating the effect of dietary counselling are therefore needed. However, it is important 
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to describe the population well, and interventions should be randomized and easily replicated. 
There is a need for higher focus on compliance as well as attrition. Eligibility criteria should 
probably be narrower to ensure that treatment effect is not diluted due to inclusion of patients 
in whom treatment effect is not anticipated. It is furthermore necessary to ensure that all 
patients receive good symptomatic treatment in order to have the possibility to reasonably 
valuate the effect of the dietary interventions. It is not to be expected that patients will be able 
to comply with dietary interventions if nutritional impact symptoms such as constipation, 
stomatitis and pain is left untreated. In cachexia nutrition probably needs to be combined with 
treatment trying to modify inflammation/catabolism. 
 
5. Conclusion 
Based on the limited number of conducted studies, the inconsistent results, as well as the 
moderate quality of the included studies, it is not possible to conclude firmly on the 
effectiveness of dietary interventions in advanced cancer and cachexia. This review shows 
that dietary counselling can have some effect on body weight and energy intake although 
heterogeneity between studies is present. Few studies measured energy intake in this review, 
but itseems that dietary interventions can improve energy intake. Still, the increase in energy 
intake seems not transferable to improvement in patients’ weight. This observation 
emphasizes the correctness of the international cachexia definition stating that cachexia 
cannot be treated with nutrition alone. It was not possible to give information on whether 
there were differences in the effectiveness of dietary treatment between patients having pre-
cachexia, cachexia or refractory cachexia.  
This review highlights that dietary intervention trials generally report poorly both when 
characterising patient populations and when describing the nutritional intervention. In order to 
advance the evidence for dietary interventions, it is mandatory that future studies take this into 
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account. However,  nutrition is a crucial part of a multimodal cachexia intervention, and it is 
not plausible to increase or stabilise weight if nutritional needs are not met. 
 
Conflict of interest 
The authors have no conflict of interest associated with this manuscript.    
Acknowledgements 
The authors thanks Ingrid Riphagen, trained research advisor, Unit for Applied Clinical 
Research, Faculty of Medicine NTNU, for help with the systematic searches and valuable 
input on the process.    
 19 
References 
1. Evans WJ, Morley JE, Argiles J et al. Cachexia: a new definition. Clin Nutr 2008; 27: 
793-799. 
2. Fearon K, Strasser F, Anker SD et al. Definition and classification of cancer cachexia: 
an international consensus. The Lancet Oncology 2011; 12: 489-495. 
3. Blum D, Omlin A, Baracos VE et al. Cancer cachexia: a systematic literature review 
of items and domains associated with involuntary weight loss in cancer. Crit Rev Oncol 
Hematol 2011; 80: 114-144. 
4. Blum D, Omlin A, Fearon K et al. Evolving classification systems for cancer cachexia: 
ready for clinical practice? Support Care Cancer 2010. 
5. Blum D, Strasser F. Cachexia assessment tools. Current Opinion in Supportive & 
Palliative Care 2011; 5: 350-355. 
6. Fearon K, Arends J, Baracos V. Understanding the mechanisms and treatment options 
in cancer cachexia. Nat Rev Clin Oncol 2013; 10: 90-99. 
7. Oberholzer R, Hopkinson JB, Baumann K et al. Psychosocial Effects of Cancer 
Cachexia: A Systematic Literature Search and Qualitative Analysis. Journal of pain and 
symptom management 2013; 46: 77-95. 
8. Wallengren O, Lundholm K, Bosaeus I. Diet energy density and energy intake in 
palliative care cancer patients. Clinical Nutrition 2005; 24: 266-273. 
9. Isenring EA, Bauer JD, Capra S. Nutrition support using the American Dietetic 
Association medical nutrition therapy protocol for radiation oncology patients improves 
dietary intake compared with standard practice. In Journal of the American Dietetic 
Association. 2007; 404-412. 
10. Radbruch L, Elsner F, Trottenberg P et al. Clinical practice guidelines on cancer 
cachexia in advanced cancer patients. In. Aachen: Department of Palliative Medicin/European 
Palliative Care Research Collaborative 2010. 
11. Koretz RL. Should patients with cancer be offered nutritional support: does the benefit 
outweigh the burden? Eur J Gastroenterol Hepatol 2007; 19: 379-382. 
12. Liberati A, Altman DG, Tetzlaff J et al. The PRISMA statement for reporting 
systematic reviews and meta-analyses of studies that evaluate healthcare interventions: 
explanation and elaboration. BMJ 2009; 339. 
13. Higgins J, Green S. Cochrane handbook for systematic reviews of interventions. . In 
Version 5.1.0 Edition. The Cochrane Collaboration 2011. 
14. Ovesen L, Allingstrup L, Hannibal J et al. Effect of dietary counseling on food intake, 
body weight, response rate, survival, and quality of life in cancer patients undergoing 
chemotherapy: a prospective, randomized study. In Journal of clinical oncology : official 
journal of the American Society of Clinical Oncology. 1993; 2043-2049. 
15. Lovik A, Almendingen K, Dotterud M et al. [Dietary information after radiotherapy of 
head and neck cancer]. Tidsskr Nor Laegeforen 1996; 116: 2303-2306. 
16. Isenring EA, Capra S, Bauer JD. Nutrition intervention is beneficial in oncology 
outpatients receiving radiotherapy to the gastrointestinal or head and neck area. In British 
journal of cancer. 2004; 447-452. 
17. Casas F, Leon C, Jovell E et al. Adapted ice cream as a nutritional supplement in 
cancer patients: Impact on quality of life and nutritional status. Clinical and Translational 
Oncology 2012; 14 (1): 66-72. 
18. Valentini V, Marazzi F, Bossola M et al. Nutritional counselling and oral nutritional 
supplements in head and neck cancer patients undergoing chemoradiotherapy. J Hum Nutr 
Diet 2012; 25: 201-208. 
 20 
19. Persson CR, Johansson BBK, Sjoden P-O, Glimelius BLG. A randomized study of 
nutritional support in patients with colorectal and gastric cancer. Nutrition & Cancer 42: 48-
58. 
20. Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME. Dietary counseling improves 
patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients 
undergoing radiotherapy. In Journal of clinical oncology : official journal of the American 
Society of Clinical Oncology. 2005; 1431-1438. 
21. Ravasco P, Monteiro-Grillo I, Marques Vidal P, Camilo ME. Impact of nutrition on 
outcome: a prospective randomized controlled trial in patients with head and neck cancer 
undergoing radiotherapy. In Head & neck. 2005; 659-668. 
22. Dixon J. Effect of nursing interventions on nutritional and performance status in 
cancer patients. In Nursing research. 1984; 330-335. 
23. Paccagnella A, Morello M, Da Mosto MC et al. Early nutritional intervention 
improves treatment tolerance and outcomes in head and neck cancer patients undergoing 
concurrent chemoradiotherapy. Support Care Cancer 2010; 18: 837-845. 
24. Bauer J, Capra S, Battistutta D et al. Compliance with nutrition prescription improves 
outcomes in patients with unresectable pancreatic cancer. In Clinical nutrition (Edinburgh, 
Scotland). 2005; 998-1004. 
25. Daly JM, Weintraub FN, Shou J et al. Enteral nutrition during multimodality therapy 
in upper gastrointestinal cancer patients. In Annals of surgery. 1995; 327-338. 
26. Mercuri A, Joon DL, Wada M et al. The effect of an intensive nutritional program on 
daily set-up variations and radiotherapy planning margins of head and neck cancer patients. 
Journal of Medical Imaging and Radiation Oncology 2009; 53 (5): 500-505. 
27. Wallengren O, Bosaeus I, Lundholm K. Dietary energy density, inflammation and 
energy balance in palliative care cancer patients. Clin Nutr 2013; 32: 88-92. 
28. Wang CH, Wang HM, Pang YP, Yeh KY. Early nutritional support in non-metastatic 
stage IV oral cavity cancer patients undergoing adjuvant concurrent chemoradiotherapy: 
analysis of treatment tolerance and outcome in an area endemic for betel quid chewing. 
Support Care Cancer 2012; 20: 1169-1174. 
29. Baldwin C, Spiro A, McGough C et al. Simple nutritional intervention in patients with 
advanced cancers of the gastrointestinal tract, non-small cell lung cancers or mesothelioma 
and weight loss receiving chemotherapy: a randomised controlled trial. J Hum Nutr Diet 
2011; 24: 431-440. 
30. Breitkreutz R, Tesdal K, Jentschura D et al. Effects of a high-fat diet on body 
composition in cancer patients receiving chemotherapy: a randomized controlled study. In 
Wiener klinische Wochenschrift. 2005; 685-692. 
31. van den Berg MG, Rasmussen-Conrad EL, Wei KH et al. Comparison of the effect of 
individual dietary counselling and of standard nutritional care on weight loss in patients with 
head and neck cancer undergoing radiotherapy. Br J Nutr 2010; 104: 872-877. 
32. Evans WK, Nixon DW, Daly JM et al. A randomized study of oral nutritional support 
versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-
cell lung cancer. J Clin Oncol 1987; 5: 113-124. 
33. Percival C, Hussain A, Zadora-Chrzastowska S et al. Providing nutritional support to 
patients with thoracic cancer: Findings of a dedicated rehabilitation service. Respiratory 
Medicine 2013; 107: 753-761. 
34. Baldwin C, Spiro A, Ahern R, Emery PW. Oral Nutritional Interventions in 
Malnourished Patients With Cancer: A Systematic Review and Meta-Analysis. Journal of the 
National Cancer Institute 2012; 104: 371-385. 
35. Tisdale MJ. Mechanisms of cancer cachexia. Physiol Rev 2009; 89: 381-410. 
 21 
36. Bosaeus I. Nutritional support in multimodal therapy for cancer cachexia. Supportive 
Care in Cancer 2008; 16: 447-451. 
37. Solheim TS, Laird BJ. Evidence base for multimodal therapy in cachexia. Curr Opin 
Support Palliat Care 2012; 6: 424-431. 
38. Thoresen L, Frykholm G, Lydersen S et al. Nutritional status, cachexia and survival in 
patients with advanced colorectal carcinoma. Different assessment criteria for nutritional 
status provide unequal results. Clinical Nutrition 2013; 32: 65-72. 
39. Welch RW, Antoine J-M, Berta J-L et al. Guidelines for the design, conduct and 
reporting of human intervention studies to evaluate the health benefits of foods. British 
Journal of Nutrition 2011; 106: S3-S15. 
40. Baracos VE. Clinical trials of cancer cachexia therapy, now and hereafter. J Clin 
Oncol 2013; 31: 1257-1258. 
41. Prado CM. Body composition in chemotherapy: the promising role of CT scans. Curr 
Opin Clin Nutr Metab Care 2013; 16: 525-533. 
42. Dewys WD, Begg C, Lavin PT et al. Prognostic effect of weight loss prior to 
chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980; 69: 
491-497. 
43. Baracos VEa, Pichard Cb, Attaix Dc. Survival: the relevant primary outcome for 
nutrition therapy in cancer patients. Current Opinion in Clinical Nutrition & Metabolic Care 
2012; 15: 211-212. 
 
 
Bibliography 
Asta Bye (Dietician, PhD) has a research position at the Regional Centre for Excellence in 
Palliative Care at Oslo University Hospital. She also holds a position as associate professor at 
the Department of Health, Nutrition and Management, Oslo and Akershus University College 
of Applied Sciences.  
 
 
 
 22 
Table 1.  Characteristics of studies investigating the effects of dietary counselling in patients with cancer cachexia. 
 Patients 
 
 Results Effects 
Author, 
year and 
study design 
Total 
no. of 
patients 
Patient 
characteristics 
Intervention Duration of 
intervention 
Outcomes1 Body weight  Other outcomes Effect on  
weight and 
energy intake 
Effect on QoL 
and physical 
function 
Baldwin, 
2011 (28) 
 
RCT 
N=358 GI, NSCLC or 
mesothelioma 
 
Metastatic or 
locally 
advanced 
disease 
 
Palliative 
chemotherapy 
 
Group 1, Dietary advice to increase 
intake by 600 kcal per day. Booklet with 
commonly used foods and snacks in 
portion sizes each providing 150 kcal 
Group 2, One sachet of ONS each day 
providing 588 kcal. A daily multivitamin 
and mineral supplement 
Group 3, Dietary advice to increase food 
intake by 600 kcal per day, one sachet of 
ONS and vitamins.  
Group 4, Control; Ad lib intake 
6 weeks 
 
After this the 
patients were 
allowed to 
continue with 
their 
intervention if 
desired 
 
1=X 
2=X 
3=X 
4=X 
 
No differences 
between the groups 
after 6 weeks 
 
After 1 year, group 
1 (N=31) had 
gained more than 
group 4 (N=37) 
(mean 4.8 kg vs. 
1.4 kg, p<0.05) 
Compliance with prescribed 
quantity of supplement fell 
during the whole study  
 
No differences in QoL 
(EORTC-C30 and FAACT) 
No differences in physical 
performance (hand grip 
strength)  
No differences in overall 
survival 
Limited effect on 
weight  
 
Energy intake 
NA. 
 
No effect  
on QoL or  
physical  
function  
 
Breitkreutz, 
2005 (29) 
 
RCT 
N=23 CRC and 
gastric cancer, 
with 
metastases  
 
Not resectable 
or advanced 
cancer 
 
Chemotherapy 
 
 
Group 1, Usual care (nutritional advice 
every 14 days) and commercial fat-
enriched ONS. The drink should provide 
at least 20 non-protein kcal/kg per day. 
100 ml of the drink contained 9.3g fat 
Group 2, Control: Usual care (nutritional 
advice every 14 days) 
 
Nutritional target for both groups was an 
intake of 35 non protein kcal/kg body 
weight per day and 1.1 g protein/kg per 
day  
56 days  1=X 
2=X 
3=X 
4=0 
 
Group 1 gained 
weight and group 2 
lost weight (mean 
+ 1.4 kg vs. -2 kg, 
p<0.05)   
 
Group 1 increased 1 kg fat 
free cell mass versus 1 kg 
loss in group 2 (p<0.05)   
Stable albumin in group 1, 
fall (-4.75 g/l) in group 2 
Energy intake higher in group 
1, 1865 kcal vs. 1556 kcal 
(NS)   
Consumption of energy from 
fat higher (66 %) in group 1 
LASA scale: Improved rating 
of leisure activities (p<0.01) 
and psychological (p<0.05) 
conditions in group 1 versus 
deterioration in the group 2 
Beneficial effect 
on weight 
 
NS effect on 
energy intake 
 
 
 
 
 
 
 
 
 
 
Limited effect 
on QoL  
 
No data  
on physical  
function  
 
van den 
Berg, 2010 
(30) 
 
Prospective 
intervention 
study 
N=38 HN (stage II-
IV) 
 
Radiotherapy 
 
 
Group 1, Systematically dietary advice 
by dietitian to meet TCN and protein 
requirement by regular food (1-2 times a 
week). High energetic ONS and EN 
were used if energy intake was too low 
Group 2, Dietary counselling twice by a 
dietitian before RT. Thereafter, weight at 
least once a week and nutritional advice 
by a nurse. Symptom management and 
ONS. EN used for patients losing>10% 
weight. Patients seen once a week during 
RT and at least once 3-4 months after 
treatment. Estimated TCN >30 -  40 
kcal kg per day  
Estimated protein 1g – 1.5g/kg per day 
20 weeks  1=X 
2=0 
3=0 
4=0 
 
Two weeks  after 
RT  
3% weight loss in 
both groups 
  
Two months after 
RT group 1 gained 
weight, group 2 
continued to lose 
(+1% vs.  
-1.5%, p=0.03) 
Two weeks after RT, lower 
prevalence of malnutrition in 
group 1 than in group 2 (0/20 
vs. 5/18, p<0.05). Two 
months after RT (1/20 vs. 
3/18, NS) 
 
Differences in malnutrition 
was not associated with 
disease stage 
Limited effect on 
weight 
 
Energy intake 
NA 
 
No data  
on QoL or  
physical  
function  
 
1Outcomes: 1: Weight (kg, % weight change), 2: Energy intake (kcal, kJ; MJ) and/or energy balance, 3: QoL parameters 4: Physical function (Karnosfky, ECOG, grip strength)  
Abbreviations: HN, head and neck cancers, TCN, total caloric need , ONS, oral nutritional supplement, EN, enteral nutrition, NS, not significant, NA, not assessed, QoL, quality of life,  RCT, randomized controlled trial, GI, 
gastrointestinal cancers, NSCLC, non-small cell lung cancer,  CRC, colorectal cancer.   
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Table 2.  Characteristics of studies investigating the effects of dietary counselling in patients with all stages of cancer cachexia. 
 
 Patients 
 
 Results Effect 
Author, 
year and 
study design 
Total 
no. of 
patients 
Patient 
characteristics 
Intervention Duration of 
intervention 
Outcomes 1 
 
Body weight  Other  Effect on  
weight and 
energy intake 
Effect on  
 QoL and 
physical 
function 
Evans, 
1987 (31) 
 
RCT 
N=180 Metastatic 
NSCLC and 
Duke’s D CRC 
 
Chemotherapy 
 
 
Group 1, Standard nutrition; dietary advice to 
meet TCN, EN if necessary  
Group 2, Augmented nutrition; Standard 
nutrition and in addition 25% of calories from 
protein, supplements of zinc and magnesium   
Group 3, Control; Ad lib intake 
24-hour recalls used to assess energy intake 
Harris Benedict equation used to calculate 
resting energy expenditure and TCN 
3 months 
 
1=X 
2=X 
3=0 
4=0 
 
NSCLC: Less weight loss 
in group 1 and 2  
than group 3 after 4 weeks   
(-0,6 kg vs. -2,1 kg, 
p=0.06) 
 
CRC: No differences  
 
NSCLC: Energy intake 
91% of TCN in group 1 
and 2 vs 62% group 3 
(p<0.01)  
 
CRC: Energy intake 92% 
of TCN in group 1 and 2 
vs 73% in group 3 
(p<0.01)  
 
Significant correlation 
between energy intake 
and weight change 
 
No effect on overall 
survival 
Limited effect 
on weight for 
NSCLC  
 
No effect for 
CRC 
 
Beneficial 
effect on 
energy intake 
in both cancer 
types  
 
No data  
on QoL or  
physical  
function  
 
Percival, 
2013 (32) 
 
Prospective 
cohort study 
N=243 Thoraic cancer 
(NSCLC stage 
I-IV, SCLC 
mesothelioma 
(local and 
extensive) 
 
Surgery 
Radiotherapy 
CRT 
Palliative Care 
Systematic screening of malnutrition after 
diagnosis. Nutritional assessments were used to 
develop an individualized nutritional plan and 
written information. Dietary counselling aimed 
to optimize intake with high protein and energy 
foods, use of fortification and snacks. ONS was 
offered to malnourished or at risk patients 
4 weeks 1=X 
2=0 
3=0 
4=0 
 
After one month, weight 
gain in 23% and stable 
weight in 46% of  not 
malnourished patients vs 
36% and 33% in  
malnourished, respectively, 
NS  
Malnutrition associated 
with a reduced survival 
(median 155 days, 
p<0.01)  
 
Patient who gained 
weight were younger 
(mean age 68 vs. 71 
years, p=0.04)    
Limited effect 
on weight 
 
Energy intake 
NA 
 
No data  
on QoL or  
physical  
function  
 
1Outcomes: 1: Weight (kg, % weight change), 2: Energy intake (kcal, kJ; MJ) and/or energy balance, 3: QoL parameters 4: Physical function (Karnosfky, ECOG, grip strength)  
Abbreviations: NSCLC, non-small cell lung cancer, CRC, colorectal cancer, TCN, total caloric need, EN, enteral nutrition, QoL, quality of life, SCLC small cell lung cancer, CRT, chemoradiotherapy, ONS, oral nutritional supplement,  
NS, not significant, NA, not assessed. 
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Table 3. Quality of studies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Author/year 
 
Design Allocation 
concealment 
Losses to follow-up 
 
Intention 
to treat 
analysis 
Blinding 
 
Sample size 
calculation 
van den Berg  
2010 
Prospective 
intervention 
study 
  38 of 38 at week 20  Not 
described 
  
Percival 
2013 
Prospective 
cohort study 
 191 of 414 at 4 weeks    
Evans 
1987 
RCT Not described 111 of 180 at 12 weeks 
 
Not 
described  
 X 
Breitkreutz 
2005 
RCT Not described 23 of 23 at day 28 
23 of 23 at day 56 
Not 
described 
  
Baldwin 
2011 
RCT X 323 of 358 at week 6 
346 of 358 at week 26 
153 of 358 at week 52 
X  X 
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Fig. 1. Flow chart summarizing the stages of the systematic review and reasons for exclusion. 
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 4 records identified through hand 
search of references lists  
534 records after duplicates removed 
 
534 records screened 
 
Records excluded (n =508) 
 Not dietary 
intervention for 
weight loss (n=266) 
 Intervention with 
parenteral and/or 
enteral nutrition 
(n=132) 
 Intervention with N-
3 fatty acids (n=25) 
 Intervention in 
cancer survivors 
(n=28) 
 Not cancer or not 
human (n=48) 
 Not adults (n=6) 
 Abstracts (n=3) 
Full-text articles assessed for 
eligibility 
(n =23) 
Full-text articles excluded, 
with reasons (n =18) 
 Not a population of 
advanced cancer 
(n=9) 
 Cachexia not 
classified and 
diagnosed (n=4) 
 Intervention not 
focussed on dietary 
counselling (n=5) 
Studies included in 
qualitative synthesis 
(n =5) 
